Sodium Channel Mutations in Glioblastoma and Survival
Author Information
Author(s): Joshi Avadhut D, Parsons D Williams, Velculescu Victor E, Riggins Gregory J
Primary Institution: Johns Hopkins University Medical School
Hypothesis
Do sodium ion channel mutations correlate with survival in glioblastoma patients?
Conclusion
Sodium channel mutations in glioblastoma patients are associated with significantly shorter survival.
Supporting Evidence
- 90% of patients had at least one mutation in ion transport genes.
- Patients with sodium channel mutations had a median survival of 148 days.
- Patients without sodium channel mutations had a median survival of 689 days.
Takeaway
This study found that patients with mutations in sodium channels tend to live shorter lives after being diagnosed with glioblastoma, and that certain drugs might help treat this condition.
Methodology
The study sequenced genes from 21 glioblastoma patients and compared survival based on sodium channel mutation status.
Limitations
The sample size is small, and the study may not account for all variables affecting survival.
Participant Demographics
The cohort included 21 patients, with 8 females and 13 males, median age of 45 years.
Statistical Information
P-Value
0.0079
Statistical Significance
p = 0.0079
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website